Farmacosmo Future Growth
Future criteria checks 4/6
Farmacosmo is forecast to grow earnings and revenue by 73.1% and 7.2% per annum respectively. EPS is expected to grow by 64.1% per annum. Return on equity is forecast to be 3.9% in 3 years.
Key information
73.1%
Earnings growth rate
64.1%
EPS growth rate
Specialty Retail earnings growth | 32.3% |
Revenue growth rate | 7.2% |
Future return on equity | 3.9% |
Analyst coverage | Low |
Last updated | 30 Apr 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 89 | 1 | 2 | 4 | 2 |
12/31/2025 | 80 | -1 | 1 | 2 | 2 |
12/31/2024 | 74 | -2 | -1 | 1 | 2 |
12/31/2023 | 72 | -3 | -7 | -5 | N/A |
9/30/2023 | 72 | -3 | N/A | N/A | N/A |
6/30/2023 | 72 | -3 | N/A | N/A | N/A |
3/31/2023 | 69 | -2 | N/A | N/A | N/A |
12/31/2022 | 67 | -1 | N/A | N/A | N/A |
6/30/2022 | 64 | 0 | N/A | N/A | N/A |
3/31/2022 | 61 | 0 | N/A | N/A | N/A |
12/31/2021 | 58 | 0 | -1 | 0 | N/A |
12/31/2020 | 44 | 0 | 1 | 2 | N/A |
12/31/2019 | 24 | 0 | -1 | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZJ1 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: ZJ1 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ZJ1 is expected to become profitable in the next 3 years.
Revenue vs Market: ZJ1's revenue (7.2% per year) is forecast to grow faster than the German market (5.4% per year).
High Growth Revenue: ZJ1's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ZJ1's Return on Equity is forecast to be low in 3 years time (3.9%).